200 Goossens, G
What are the main limitations
What This Means for Patients If you were previously on a compounded medication, transitioning to an FDA-approved GLP-1 may provide: Greater dosing precision Clearer insurance pathways Established safety profiles Long-term data Our goal is sustainable, medically guided weight loss, not short-term trends
If you are still hungry on semaglutide, it does not necessarily mean the medication is not working
These products typically contain specific bacterial strainsmost commonly Akkermansia muciniphila , Lactobacillus species, and Bifidobacterium strainsthat manufacturers claim can stimulate the body's natural production of glucagon-like peptide-1 (GLP-1)
"I knew that semaglutide would help me fill up faster and decrease my portions, but what surprised me was how quickly I responded and just how little I was eating," she says